[Pharmacological aspect of the treatment of hypotension induced by phenothiazine neuroleptics and monoamine oxidase inhibitors].
D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D004877:Ergoloid Mesylates / Q000627:therapeutic use; D006801:Humans; D007022:Hypotension / Q000139:chemically induced* / Q000188:drug therapy; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects*; D010640:Phenothiazines / Q000009:adverse effects*; D013566:Sympathomimetics / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000009:adverse effects*; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
D000697:Central Nervous System Stimulants; D008996:Monoamine Oxidase Inhibitors; D010640:Phenothiazines; D013566:Sympathomimetics; D014149:Tranquilizing Agents; D014662:Vasoconstrictor Agents; D004877:Ergoloid Mesylates
Aspect pharmacologique du traitement des hypotensions provoquées par les neuroleptiques phénothiaziniques et les inhibiteurs de la mono-amine-oxydase.